SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-228564
Filing Date
2006-11-08
Accepted
2006-11-08 17:20:58
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 615362
2 LETTER AMENDMENT, DATED OCTOBER 5, 2006 dex101.htm EX-10.1 73304
3 CERTIFICATION OF PEO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 8954
4 CERTIFICATION OF PFO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 8922
5 SECTION 1350 CERTIFICATIONS dex321.htm EX-32.1 4251
6 GRAPHIC g8080302000001.jpg GRAPHIC 3976
  Complete submission text file 0001193125-06-228564.txt   718015
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 061198506
SIC: 2834 Pharmaceutical Preparations